Senior Global Compound Market Access Leader, CVM&PH

    • Johnson & Johnson
  • Raritan, NJ
  • Posted 60+ days ago | Updated 4 hours ago


On Site
USD 187,000.00 - 280,000.00 per year
Full Time


Market research
Strategic planning
Health Care Reform
Market segmentation
Team leadership
Mergers and acquisitions
Research and Development
Pharmaceutical industry
Health care
Technology assessment
Data Science
Clinical trials
Public health
Life insurance

Job Details


Company Description

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at

Job Description

Janssen Global Commercial Strategy Organization, a group within Janssen Global Services and a member of Johnson & Johnson's family of companies, is recruiting for a Global Compound Market Access Leader. This position will be based in Raritan, NJ.

The Senior Compound Market Access Leader (SCMAL) is a career pathway and talent advancement opportunity to lead the strategic planning and implementation of the payer value generation and access strategies for innovative medicines in early development to commercialization. The position resides in the Cardiovascular, Metabolic and Pulmonary Hypertension (CVM&PH) area of the Global Commercial Strategy Organization and reports to VP of Market Access for CVM&PH. For the assigned therapeutic area, the SCMAL serves as the leading resource on access strategies and is an active member of the global clinical and commercial product teams, as well as the disease area strategy groups. They will be responsible for integrating pricing, market research, and epidemiology information to develop the optimal value strategy. The SCMAL will be responsible for the following activities in their disease area:

Market Access Strategy:
  • Leads the Compound Market Access Team (CMAT) across parallel indications, which includes the core functions within Global Market Access (i.e., Health Economics, Patient Reported Outcomes [PRO], Access Policy, Pricing, Real-World Evidence & Analytics) to deliver the global market access strategy & key value communication tools for the brand.
  • Design, develop and implements an integrated approach to all aspects of the payer value proposition from early development through and beyond loss of exclusivity for a complex portfolio of compounds and indications.
  • Responsible for the strategic planning and implementation of the payer value generation and access strategies.
  • Serve as the leading resource on access strategies and is an active member of the global clinical and commercial product teams, as well as the disease area strategy groups.
  • Responsible for integrating pricing, payer research, health economic and epidemiology information to develop the optimal value strategy.
  • Interact with Regional Market Access/Health Economics / Outcomes Research and Medical Affairs teams to coordinate and develop real world evidence generation in support of their access programs.
  • Develop an integrated access strategy that reflects macro (health care reform, quality metrics, technology assessment) and disease specific (clinical profile, market segmentation, disease staging and clinical pathway) factors as well as the complexity of a companion diagnostic.
  • Be responsible for ensuring that clinical development programs fully capture the value of innovative products to payers, physicians and patients. This includes strategic advice to teams on patient populations, trial design, selection of relevant endpoints as well as ensuring quality implementation of study protocols, case report forms, monitoring protocols, statistical analyses plans, etc.
  • Drive the design and management of health outcomes studies including: systematic literature reviews, Real World Evidence studies, and user-friendly cost effectiveness and budget impact models.
  • Be responsible for educating the commercial and R&D teams on key access trends and opportunities to shape their evolution.
  • Provide leadership to the Clinical Development Team (CDT) in terms of market access data needs related to the clinical development plan; represent the access needs of the regions as a subject matter expert and advocate for the data necessary for positive reimbursement across the global markets.
  • Take budgetary responsibility for defining and managing the market access discretionary budgets, ensuring that spending is managed effectively throughout the year and to plan.
  • Develop deep expertise of the clinical and market access drivers unique to cell-based therapies and work to drive the debate externally to influence market access and reimbursement approaches to these novel therapies.
  • Keep up to date with scientific developments, bringing the latest techniques and analyses to build the strongest possible value proposition.
  • Understand the patient perspective of the disease and recommend strategies that can support the patient voice in key payer negotiations.

Team Leadership:
  • Lead a team including Compound Market Access Leaders (CMALs) and/or Associate CMALs.
  • Develop, coach and train team members on own team as well as within broader MA organization.
  • Recruit and build pipeline for the team.
  • Strategic alignment across Regions and Countries:
  • Lead an engaged and collaborative Extended Market Access team, ensuring great communication and collaboration, sharing of best practice and co-creation.
  • To enable timely reimbursement and patient access, proactively support engagements with key external decision makers to reach a consensus on acceptable evidentiary requirements.
  • Partner on the design of payer research and provide support early scientific advice.
  • Work with pricing colleagues to provide expert perspectives and establish pricing policies.
  • Oversee the evaluation and modelling of innovative pricing and contracting initiatives and support execution.
  • Foster collaboration, alignment and seamless working across R&D and GCSO functions, including the Clinical Development Team (CDT), Commercial, Medical Affairs, and Global Market Access COE to ensure optimal launch readiness for the brand.

Required Education & Experience:
  • Master's Degree
  • 10 years of professional experience in the pharmaceutical industry (global, regional or operating company level) with a focus in Epidemiology, Health Economics, Payer Access.
  • 8 years of experience managing large groups and projects.

Required Skills:
  • Market Access Landscape: The ability to shape the evolving payer landscape by researching, developing, and maintaining a deep understanding of payers and their perspectives in the key global markets. This includes knowledge of trends in pricing, reimbursement, healthcare policy, and all market archetypes.
  • Healthcare Ecosystem: Knowledge of and ability to assess and navigate the evolving external healthcare environment to create policy strategies for product or disease area and influence policymaking institutions. This includes an understanding of global healthcare systems and policies and how they impact local and regional efforts.
  • Health Technology Assessment: Knowledge of the principles of evidence-based medicine and methodologies to evaluate health-related technology and deliver product dossiers.
  • Market Access Analytics: The ability to systematically gather and analyze information from various sources, including modeling, pricing, and contracting strategies. This includes the ability to generate data to support real-world evidence, identify and communicate patterns and trends, and evaluate and develop strategic plans.
  • Evidence Generation: The ability to apply data science concepts and methodologies to identify and articulate value propositions, create and implement value strategies, generate business insights, and drive evidence generation and debate on the appropriateness of conclusions. This includes providing market access inputs to clinical trial design, implementation, and analyses and knowledge of meta-analysis as well as epidemiologic studies.
  • Clinical Trial Methodology: Knowledge of clinical trials and trial design. This includes applying knowledge to recommend study design plan and methodology, considering trade-offs of different approaches, and developing hypotheses to test primary versus secondary endpoints and implications for labeling.

Preferred Education & Experience:
  • Ph.D., Pharm D, MD, or M.Sc. in appropriate field (preferably Epidemiology, Health Economics, Public Health, Health Policy).
  • Experience in multiple therapy areas.
  • Demonstrated leadership ability to successfully work across functional and geographic boundaries, preferably across multiple countries/market types/access models.

Johnson & Johnson is an Affirmative Action and Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

The anticipated base pay range for this position is 187 000 USD to 280 000 USD.

The Company maintains highly competitive, performance-based compensation programs. Under current guidelines, this position is eligible for an annual performance bonus in accordance with the terms of the applicable plan. The annual performance bonus is a cash bonus intended to provide an incentive to achieve annual targeted results by rewarding for individual and the corporation's performance over a calendar/performance year. Bonuses are awarded at the Company's discretion on an individual basis.
  • Employees and/or eligible dependents may be eligible to participate in the following Company sponsored employee benefit programs: medical, dental, vision, life insurance, short- and long-term disability, business accident insurance, and group legal insurance.
  • Employees may be eligible to participate in the Company's consolidated retirement plan (pension) and savings plan (401(k)).
  • Employees are eligible for the following time off benefits:
    Vacation - up to 120 hours per calendar year
    Sick time - up to 40 hours per calendar year
    Holiday pay, including Floating Holidays - up to 13 days per calendar year
    Work, Personal and Family Time - up to 40 hours per calendar year
    For additional general information on company benefits please go to:

For more information on how we support the whole health of our employees throughout their wellness, career and life journey, please visit .
Employers have access to artificial intelligence language tools (“AI”) that help generate and enhance job descriptions and AI may have been used to create this description. The position description has been reviewed for accuracy and Dice believes it to correctly reflect the job opportunity.